HEADER CELL ADHESION/CELL CYCLE 07-APR-04 1T08 TITLE CRYSTAL STRUCTURE OF BETA-CATENIN/ICAT HELICAL DOMAIN/UNPHOSPHORYLATED TITLE 2 APC R3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-CATENIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ARMADILLO REPEAT (RESIDUES 146-664); COMPND 5 SYNONYM: CADHERIN-ASSOCIATED PROTEIN; PRO2286; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-CATENIN-INTERACTING PROTEIN 1; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: HELICAL DOMAIN (RESIDUES 8-53); COMPND 11 SYNONYM: BETA-CATENIN-INTERACTING PROTEIN ICAT; INHIBITOR OF BETA- COMPND 12 CATENIN AND TCF-4; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: ADENOMATOUS POLYPOSIS COLI PROTEIN; COMPND 16 CHAIN: C; COMPND 17 FRAGMENT: REPEAT 3 (RESIDUES 1484-1498); COMPND 18 SYNONYM: APC; APC PROTEIN; COMPND 19 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTNNB1,CTNNB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEXHT; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CTNNBIP1,ICAT; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PPROEXHT; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 GENE: APC,DP2.5; SOURCE 26 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 28 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 29 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 30 EXPRESSION_SYSTEM_PLASMID: PGEXTEV KEYWDS BETA-CATENIN; WNT SIGNAL; APC; 20MER REPEAT; WNT SIGNALING, CELL KEYWDS 2 ADHESION-CELL CYCLE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.-C.HA,T.TONOZUKA,J.L.STAMOS,W.I.WEIS REVDAT 3 23-AUG-23 1T08 1 REMARK REVDAT 2 24-FEB-09 1T08 1 VERSN REVDAT 1 12-OCT-04 1T08 0 JRNL AUTH N.-C.HA,T.TONOZUKA,J.L.STAMOS,H.J.CHOI,W.I.WEIS JRNL TITL MECHANISM OF PHOSPHORYLATION-DEPENDENT BINDING OF APC TO JRNL TITL 2 BETA-CATENIN AND ITS ROLE IN BETA-CATENIN DEGRADATION JRNL REF MOL.CELL V. 15 511 2004 JRNL REFN ISSN 1097-2765 JRNL PMID 15327768 JRNL DOI 10.1016/J.MOLCEL.2004.08.010 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 465671.860 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 45577 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2280 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6848 REMARK 3 BIN R VALUE (WORKING SET) : 0.2930 REMARK 3 BIN FREE R VALUE : 0.3150 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 334 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4370 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 327 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.41000 REMARK 3 B22 (A**2) : 3.93000 REMARK 3 B33 (A**2) : -2.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.28 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.310 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.090 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.390 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.500 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 45.25 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1T08 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-04. REMARK 100 THE DEPOSITION ID IS D_1000022149. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-03; NULL; NULL REMARK 200 TEMPERATURE (KELVIN) : 100; NULL; NULL REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; NULL; NULL REMARK 200 RADIATION SOURCE : SSRL; NULL; NULL REMARK 200 BEAMLINE : BL11-1; NULL; NULL REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000; NULL; NULL REMARK 200 MONOCHROMATOR : MIRROR; MIRROR; MIRROR REMARK 200 OPTICS : NULL; NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; NULL; NULL REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4; NULL; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47853 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 2.670 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.29600 REMARK 200 R SYM FOR SHELL (I) : 0.29600 REMARK 200 FOR SHELL : 2.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH; SINGLE REMARK 200 WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1M1E REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3400, POTASSIUM PHOSPHATE, PH 6.5, REMARK 280 EVAPORATION, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 48.23600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.35600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 48.23600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.35600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 550 REMARK 465 THR A 551 REMARK 465 SER A 552 REMARK 465 MET A 553 REMARK 465 GLY A 554 REMARK 465 GLY A 555 REMARK 465 THR A 556 REMARK 465 GLN A 557 REMARK 465 GLN A 558 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN A 601 OE1 GLN A 601 2655 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 151 -61.42 -120.21 REMARK 500 ALA A 152 -72.34 -47.07 REMARK 500 ASP A 164 87.25 -69.29 REMARK 500 GLN A 165 -16.67 -47.27 REMARK 500 LEU A 286 1.08 -66.31 REMARK 500 THR A 393 10.12 -64.90 REMARK 500 SER B 50 -76.60 -56.56 REMARK 500 ALA C1492 75.63 -151.37 REMARK 500 SER C1495 -93.64 -129.91 REMARK 500 REMARK 500 REMARK: NULL DBREF 1T08 A 146 664 UNP P35222 CTNB1_HUMAN 146 664 DBREF 1T08 B 8 53 UNP Q9NSA3 CNBP1_HUMAN 8 53 DBREF 1T08 C 1484 1498 UNP P25054 APC_HUMAN 1484 1498 SEQRES 1 A 519 ALA GLU LEU ALA THR ARG ALA ILE PRO GLU LEU THR LYS SEQRES 2 A 519 LEU LEU ASN ASP GLU ASP GLN VAL VAL VAL ASN LYS ALA SEQRES 3 A 519 ALA VAL MET VAL HIS GLN LEU SER LYS LYS GLU ALA SER SEQRES 4 A 519 ARG HIS ALA ILE MET ARG SER PRO GLN MET VAL SER ALA SEQRES 5 A 519 ILE VAL ARG THR MET GLN ASN THR ASN ASP VAL GLU THR SEQRES 6 A 519 ALA ARG CYS THR ALA GLY THR LEU HIS ASN LEU SER HIS SEQRES 7 A 519 HIS ARG GLU GLY LEU LEU ALA ILE PHE LYS SER GLY GLY SEQRES 8 A 519 ILE PRO ALA LEU VAL LYS MET LEU GLY SER PRO VAL ASP SEQRES 9 A 519 SER VAL LEU PHE TYR ALA ILE THR THR LEU HIS ASN LEU SEQRES 10 A 519 LEU LEU HIS GLN GLU GLY ALA LYS MET ALA VAL ARG LEU SEQRES 11 A 519 ALA GLY GLY LEU GLN LYS MET VAL ALA LEU LEU ASN LYS SEQRES 12 A 519 THR ASN VAL LYS PHE LEU ALA ILE THR THR ASP CYS LEU SEQRES 13 A 519 GLN ILE LEU ALA TYR GLY ASN GLN GLU SER LYS LEU ILE SEQRES 14 A 519 ILE LEU ALA SER GLY GLY PRO GLN ALA LEU VAL ASN ILE SEQRES 15 A 519 MET ARG THR TYR THR TYR GLU LYS LEU LEU TRP THR THR SEQRES 16 A 519 SER ARG VAL LEU LYS VAL LEU SER VAL CYS SER SER ASN SEQRES 17 A 519 LYS PRO ALA ILE VAL GLU ALA GLY GLY MET GLN ALA LEU SEQRES 18 A 519 GLY LEU HIS LEU THR ASP PRO SER GLN ARG LEU VAL GLN SEQRES 19 A 519 ASN CYS LEU TRP THR LEU ARG ASN LEU SER ASP ALA ALA SEQRES 20 A 519 THR LYS GLN GLU GLY MET GLU GLY LEU LEU GLY THR LEU SEQRES 21 A 519 VAL GLN LEU LEU GLY SER ASP ASP ILE ASN VAL VAL THR SEQRES 22 A 519 CYS ALA ALA GLY ILE LEU SER ASN LEU THR CYS ASN ASN SEQRES 23 A 519 TYR LYS ASN LYS MET MET VAL CYS GLN VAL GLY GLY ILE SEQRES 24 A 519 GLU ALA LEU VAL ARG THR VAL LEU ARG ALA GLY ASP ARG SEQRES 25 A 519 GLU ASP ILE THR GLU PRO ALA ILE CYS ALA LEU ARG HIS SEQRES 26 A 519 LEU THR SER ARG HIS GLN GLU ALA GLU MET ALA GLN ASN SEQRES 27 A 519 ALA VAL ARG LEU HIS TYR GLY LEU PRO VAL VAL VAL LYS SEQRES 28 A 519 LEU LEU HIS PRO PRO SER HIS TRP PRO LEU ILE LYS ALA SEQRES 29 A 519 THR VAL GLY LEU ILE ARG ASN LEU ALA LEU CYS PRO ALA SEQRES 30 A 519 ASN HIS ALA PRO LEU ARG GLU GLN GLY ALA ILE PRO ARG SEQRES 31 A 519 LEU VAL GLN LEU LEU VAL ARG ALA HIS GLN ASP THR GLN SEQRES 32 A 519 ARG ARG THR SER MET GLY GLY THR GLN GLN GLN PHE VAL SEQRES 33 A 519 GLU GLY VAL ARG MET GLU GLU ILE VAL GLU GLY CYS THR SEQRES 34 A 519 GLY ALA LEU HIS ILE LEU ALA ARG ASP VAL HIS ASN ARG SEQRES 35 A 519 ILE VAL ILE ARG GLY LEU ASN THR ILE PRO LEU PHE VAL SEQRES 36 A 519 GLN LEU LEU TYR SER PRO ILE GLU ASN ILE GLN ARG VAL SEQRES 37 A 519 ALA ALA GLY VAL LEU CYS GLU LEU ALA GLN ASP LYS GLU SEQRES 38 A 519 ALA ALA GLU ALA ILE GLU ALA GLU GLY ALA THR ALA PRO SEQRES 39 A 519 LEU THR GLU LEU LEU HIS SER ARG ASN GLU GLY VAL ALA SEQRES 40 A 519 THR TYR ALA ALA ALA VAL LEU PHE ARG MET SER GLU SEQRES 1 B 46 GLY LYS SER PRO GLU GLU MET TYR ILE GLN GLN LYS VAL SEQRES 2 B 46 ARG VAL LEU LEU MET LEU ARG LYS MET GLY SER ASN LEU SEQRES 3 B 46 THR ALA SER GLU GLU GLU PHE LEU ARG THR TYR ALA GLY SEQRES 4 B 46 VAL VAL ASN SER GLN LEU SER SEQRES 1 C 15 ASP ALA ASP THR LEU LEU HIS PHE ALA THR GLU SER THR SEQRES 2 C 15 PRO ASP FORMUL 4 HOH *327(H2 O) HELIX 1 1 ALA A 146 ARG A 151 1 6 HELIX 2 2 ARG A 151 LEU A 160 1 10 HELIX 3 3 ASP A 164 LYS A 180 1 17 HELIX 4 4 LYS A 181 ARG A 190 1 10 HELIX 5 5 SER A 191 GLN A 203 1 13 HELIX 6 6 ASP A 207 SER A 222 1 16 HELIX 7 7 HIS A 224 SER A 234 1 11 HELIX 8 8 GLY A 235 MET A 243 1 9 HELIX 9 9 LEU A 244 SER A 246 5 3 HELIX 10 10 VAL A 248 GLN A 266 1 19 HELIX 11 11 GLY A 268 ALA A 276 1 9 HELIX 12 12 GLY A 277 LEU A 286 1 10 HELIX 13 13 ASN A 290 TYR A 306 1 17 HELIX 14 14 ASN A 308 SER A 318 1 11 HELIX 15 15 GLY A 319 TYR A 331 1 13 HELIX 16 16 TYR A 333 SER A 348 1 16 HELIX 17 17 SER A 352 ALA A 360 1 9 HELIX 18 18 GLY A 361 LEU A 368 1 8 HELIX 19 19 SER A 374 ASP A 390 1 17 HELIX 20 20 MET A 398 LEU A 409 1 12 HELIX 21 21 ASP A 413 THR A 428 1 16 HELIX 22 22 ASN A 431 VAL A 441 1 11 HELIX 23 23 GLY A 442 GLY A 455 1 14 HELIX 24 24 ARG A 457 THR A 472 1 16 HELIX 25 25 GLU A 477 HIS A 488 1 12 HELIX 26 26 GLY A 490 LEU A 497 1 8 HELIX 27 27 HIS A 503 ALA A 518 1 16 HELIX 28 28 LEU A 519 ALA A 522 5 4 HELIX 29 29 ASN A 523 GLN A 530 1 8 HELIX 30 30 GLY A 531 ARG A 549 1 19 HELIX 31 31 ARG A 565 ALA A 581 1 17 HELIX 32 32 ASP A 583 LEU A 593 1 11 HELIX 33 33 THR A 595 LEU A 603 1 9 HELIX 34 34 ILE A 607 ALA A 622 1 16 HELIX 35 35 ASP A 624 GLU A 634 1 11 HELIX 36 36 ALA A 636 LEU A 644 1 9 HELIX 37 37 ASN A 648 GLU A 664 1 17 HELIX 38 38 SER B 10 MET B 29 1 20 HELIX 39 39 THR B 34 TYR B 44 1 11 HELIX 40 40 TYR B 44 SER B 53 1 10 CISPEP 1 PRO A 500 PRO A 501 0 0.44 CRYST1 96.472 96.712 86.395 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010366 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010340 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011575 0.00000